mofezolac has been researched along with Abnormalities, Autosome in 1 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
| Excerpt | Relevance | Reference |
|---|---|---|
| "2%) of chromosomes were observed in the groups of dosing 600 micrograms/ml with dose dependency." | 1.28 | Mutagenicity tests of mofezolac (N-22). ( Furukawa, A; Ohuchida, A, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohuchida, A | 1 |
| Furukawa, A | 1 |
1 other study available for mofezolac and Abnormalities, Autosome
| Article | Year |
|---|---|
Mutagenicity tests of mofezolac (N-22).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biotransformation; Cells, Cultured; Chromosome Abe | 1990 |